Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Sales/Fixed Asset

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.832.832.502.571.94

What is the latest Sales/Fixed Asset ratio of BETA DRUGS ?

The latest Sales/Fixed Asset ratio of BETA DRUGS is 2.83 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.83
Mar20242.83
Mar20232.50
Mar20222.57
Mar20211.94

How is Sales/Fixed Asset of BETA DRUGS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.83
0.00
Mar2024 2.83
13.20
Mar2023 2.5
-2.72
Mar2022 2.57
32.47
Mar2021 1.94 -

Other Financial Ratios of BETA DRUGS


Compare Sales/Fixed Asset ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,329.6 Cr 1.2% -7.2% 13.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

1.2%

-7.2%

13.9%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses